These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11808886)
1. Salbutamol for hyperkalaemia in children. Helfrich E; de Vries TW; van Roon EN Acta Paediatr; 2001 Nov; 90(11):1213-6. PubMed ID: 11808886 [TBL] [Abstract][Full Text] [Related]
2. Treatment of hyperkalaemia in renal failure with salbutamol inhalation. Montoliu J; Almirall J; Ponz E; Campistol JM; Revert L J Intern Med; 1990 Jul; 228(1):35-7. PubMed ID: 2384735 [TBL] [Abstract][Full Text] [Related]
3. Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol. Kemper MJ; Harps E; Hellwege HH; Müller-Wiefel DE Eur J Pediatr; 1996 Jun; 155(6):495-7. PubMed ID: 8789768 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. Ngugi NN; McLigeyo SO; Kayima JK East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416 [TBL] [Abstract][Full Text] [Related]
5. Hyperkalemia: therapeutic options in acute and chronic renal failure. Kemper MJ; Harps E; Müller-Wiefel DE Clin Nephrol; 1996 Jul; 46(1):67-9. PubMed ID: 8832156 [TBL] [Abstract][Full Text] [Related]
6. Treatment of hyperkalaemia using intravenous and nebulised salbutamol. McClure RJ; Prasad VK; Brocklebank JT Arch Dis Child; 1994 Feb; 70(2):126-8. PubMed ID: 8129434 [TBL] [Abstract][Full Text] [Related]
7. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? Mandelberg A; Krupnik Z; Houri S; Smetana S; Gilad E; Matas Z; Priel IE Chest; 1999 Mar; 115(3):617-22. PubMed ID: 10084465 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hyperkalaemia with intravenous salbutamol. Murdoch IA; Dos Anjos R; Haycock GB Arch Dis Child; 1991 Apr; 66(4):527-8. PubMed ID: 2031614 [TBL] [Abstract][Full Text] [Related]
9. [Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency]. Arias-Reyes JA; Matos-Martínez M; Velásquez-Jones L; Dubey-Ortega LA Bol Med Hosp Infant Mex; 1989 Sep; 46(9):603-6. PubMed ID: 2604875 [TBL] [Abstract][Full Text] [Related]
10. A warning for the treatment of hyperkalaemia with salbutamol. Semmekrot BA; Monnens LA Eur J Pediatr; 1997 May; 156(5):420. PubMed ID: 9177992 [No Abstract] [Full Text] [Related]
11. [Use of salbutamol in the treatment of severe hyperkalemia in hemodialysed patients]. de Cornelissen F; Bermudes H; Saint-Loubert M; Marty L; Emond C; Fontanier P Presse Med; 1989 Jun; 18(25):1243-4. PubMed ID: 2525773 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and therapy of non-oliguric hyperkalaemia of the premature infant. Mildenberger E; Versmold HT Eur J Pediatr; 2002 Aug; 161(8):415-22. PubMed ID: 12172823 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hyperkalemia in children with intravenous salbutamol. Noyan A; Anarat A; Pirti M; Yurdakul Z Acta Paediatr Jpn; 1995 Jun; 37(3):355-7. PubMed ID: 7645387 [TBL] [Abstract][Full Text] [Related]
14. Management of hyperkalaemia. Maxwell AP; Linden K; O'Donnell S; Hamilton PK; McVeigh GE J R Coll Physicians Edinb; 2013; 43(3):246-51. PubMed ID: 24087806 [TBL] [Abstract][Full Text] [Related]
15. Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Liou HH; Chiang SS; Wu SC; Yang WC; Huang TP Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):276-81. PubMed ID: 8039040 [TBL] [Abstract][Full Text] [Related]
16. Interventions for non-oliguric hyperkalaemia in preterm neonates. Vemgal P; Ohlsson A Cochrane Database Syst Rev; 2007 Jan; (1):CD005257. PubMed ID: 17253550 [TBL] [Abstract][Full Text] [Related]
17. Emergency interventions for hyperkalaemia. Mahoney BA; Smith WA; Lo DS; Tsoi K; Tonelli M; Clase CM Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003235. PubMed ID: 15846652 [TBL] [Abstract][Full Text] [Related]
18. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients. Kim HJ J Korean Med Sci; 1997 Apr; 12(2):111-6. PubMed ID: 9170015 [TBL] [Abstract][Full Text] [Related]
19. Management of hyperkalemia in dialysis patients. Putcha N; Allon M Semin Dial; 2007; 20(5):431-9. PubMed ID: 17897250 [TBL] [Abstract][Full Text] [Related]
20. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Liou HH; Chiang SS; Wu SC; Huang TP; Campese VM; Smogorzewski M; Yang WC Am J Kidney Dis; 1994 Feb; 23(2):266-71. PubMed ID: 8311086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]